Results 51 to 60 of about 1,617,259 (311)

OSTKREUZ – Agency of Photographers: Balancing Legacy and Adaptation in a Photographic Landscape after German Reunification

open access: yesActa Academiae Artium Vilnensis
Founded in 1990 by seven East German photographers, OSTKREUZ—Agency of Photographers emerged as a survival strategy in post-reunification Germany, drawing on its GDR identity to establish itself in a competitive market.
Anne Pfautsch
doaj   +1 more source

Federal research, development, and demonstration priorities for carbon dioxide removal in the United States

open access: yesEnvironmental Research Letters, 2018
Atmospheric carbon dioxide removal (CDR) technologies may be critical to achieving deep decarbonization. Yet a lack of technical and commercial maturity of CDR technologies hinders potential deployment.
Daniel L Sanchez   +3 more
doaj   +1 more source

Commercial policies in frontier reductions: Models, reappropriations and disputes (Río de la Plata, 18th century)

open access: yesEstudios Fronterizos, 2018
The aim of this paper is an analysis of the commercial policy implemented by the colonial bureaucracy on the Guarani Reductions, also the adaptations, responses and conflicts this process originated.
Lía Quarleri
doaj   +1 more source

Intermediary Risk in a Global Economy [PDF]

open access: yes, 2001
Worldwide financial markets increasingly depend on structures that reduce risk by interposing intermediaries between investors and the companies obligated to pay them.
Schwarcz, Steven L.
core   +3 more sources

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

On the Waterfront: The Historic Waterfront Precinct, Dunedin, New Zealand

open access: yesPublic History Review, 2011
This article examines the industrial and mercantile built heritage of New Zealand by considering a remarkable precinct in Dunedin of surviving commercial buildings from the second half of the nineteenth century. The city was then the country’s financial,
Alexander Trapeznik
doaj   +3 more sources

Fiduciaries With Conflicting Obligations [PDF]

open access: yes, 2010
This Article examines the dilemma of a fiduciary acting for parties who, as among themselves, have conflicting commercial interests - an inquiry fundamentally different from that of the traditional study of conflicts between fiduciaries and their ...
Schwarcz, Steven L.
core   +2 more sources

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Microgravity metal processing: from undercooled liquids to bulk metallic glasses [PDF]

open access: yes, 2015
Bulk metallic glasses (BMGs) are a novel class of metal alloys that are poised for widespread commercialization. Over 30 years of NASA and ESA (as well as other space agency) funding for both ground-based and microgravity experiments has resulted in ...
Hofmann, Douglas C., Roberts, Scott N.
core   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy